Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Impact of Tumor Biological Factors on Response to Pre-operative Epirubicin and Paclitaxel Chemotherapy in Primary Breast Cancer

MATHIAS WARM, RONALD KATES, PETER MALLMANN, MICHÈLLE DICK, FRANK NAWROTH, NADIA HARBECK, STEFAN PAEPKE and ANKE THOMAS
Anticancer Research March 2007, 27 (2) 1031-1038;
MATHIAS WARM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mathias.warm{at}ukkoeln.de
RONALD KATES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETER MALLMANN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHÈLLE DICK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANK NAWROTH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NADIA HARBECK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEFAN PAEPKE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANKE THOMAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 2 1031-1038
PMID 
17465239

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 29, 2006
  • Revision received February 6, 2007
  • Accepted February 7, 2007
  • Published online March 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. MATHIAS WARM1,
  2. RONALD KATES2,
  3. PETER MALLMANN1,
  4. MICHÈLLE DICK1,
  5. FRANK NAWROTH3,
  6. NADIA HARBECK2,
  7. STEFAN PAEPKE2 and
  8. ANKE THOMAS4
  1. 1Department of Senology, University of Cologne
  2. 2Department of Obstetrics and Gynecology, Technical University of Munich, Munich
  3. 3Endokrinologikum Hamburg, Centre for Hormone and Metabolic Diseases, Reproductive Medicine and Gynaecological Endocrinology, Hamburg
  4. 4Department of Obstetrics and Gynecology, University of Berlin, Charité, Germany
  1. Correspondence to: Dr. med. Mathias Warm, Department of Senology, Kerpener Strasse 62, 50924 Köln, Germany. Tel: +49 221 478 8 65 45, Fax: +49 221 478 8 65 46, e-mail: mathias.warm{at}ukkoeln.de

Statistics from Altmetric.com

Cited By...

  • 8 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 27, Issue 2
March-April 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Tumor Biological Factors on Response to Pre-operative Epirubicin and Paclitaxel Chemotherapy in Primary Breast Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
13 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Impact of Tumor Biological Factors on Response to Pre-operative Epirubicin and Paclitaxel Chemotherapy in Primary Breast Cancer
MATHIAS WARM, RONALD KATES, PETER MALLMANN, MICHÈLLE DICK, FRANK NAWROTH, NADIA HARBECK, STEFAN PAEPKE, ANKE THOMAS
Anticancer Research Mar 2007, 27 (2) 1031-1038;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Impact of Tumor Biological Factors on Response to Pre-operative Epirubicin and Paclitaxel Chemotherapy in Primary Breast Cancer
MATHIAS WARM, RONALD KATES, PETER MALLMANN, MICHÈLLE DICK, FRANK NAWROTH, NADIA HARBECK, STEFAN PAEPKE, ANKE THOMAS
Anticancer Research Mar 2007, 27 (2) 1031-1038;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • 3D Breast Ultrasound: A Significant Predictor in Breast Cancer Reduction under Pre-operative Chemotherapy
  • Impact of Tumor Biology, Particularly Triple-negative Status, on Response to Pre-operative Sequential, Dose-dense Epirubicin, Cyclophosphamide Followed by Docetaxel in Breast Cancer
  • Side-effects of Pre-operative Epirubicin-Paclitaxel Therapy in Primary Breast Cancer Associated with Tumor Biology
  • Google Scholar

More in this TOC Section

  • Real-world Patterns and Trends of Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer: Insights from a Large Prospective German Cohort
  • Dual Modality and Site-differentiated Sentinel Node Mapping in Vulvar Cancer
  • Pembrolizumab and Quality of Life in Recurrent or Metastatic Head and Neck Cancer
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire